Mana Hirano

No ORCID on file · 10 papers in corpus · active 2018-2025

Study types

  • article 7
  • preprint 2
  • case-report 1

Condition tags

  • endometriosis 7
  • mesh:D004715 4
  • adenomyosis 2
  • mesh:D004412 1
  • infertility 1
  • dysmenorrhea 1
  • mesh:D017699 1
case-report 2025
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
BMC women's health ·doi:10.1186/s12905-025-03681-8

BACKGROUND: Adenomyosis, characterized by endometrial tissue within the uterine muscle, often presents with severe pelvic pain and menorrhagia. This case series demonstrates the efficacy of sequential therapy involving relugolix followed by…

article 2024
Proposal for individual treatment by tubal occlusion factor based on the results of salpingoscopic salpingoplasty
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15993

AIM: As a treatment for tubal infertility, falloposcopic tuboplasty (FT) is one of the options for patients who wish to conceive naturally. Based on the results of FT, we propose an appropriate time of transitioning to assisted reproductive…

article 2024
Ulipristal (UPA) effects on rat ovaries: Unraveling follicle dynamics, ovulation inhibition, and safety implications for prolonged use
·doi:10.1016/j.reprotox.2024.108571
preprint 2023
Effect of long-term treatment of ulipristal acetate on rat ovarian tissue
·doi:10.21203/rs.3.rs-2847062/v1

Abstract Ulipristal (UPA), a selective progesterone receptor modulator, has both agonistic and antagonistic effects on progesterone receptors. UPA suppresses ovulation by inhibiting the luteinizing hormone (LH) surge from the pituitary glan…

article 2022
Evaluation of atherosclerosis-related biomarkers during perimenopause: A prospective cohort study in women with endometriosis

Aim: Endometriosis is linked to asymptomatic atherosclerosis and increases the risk of cardiovascular disease (CVD). Vascular function tests are used to assess atherosclerosis, an important indicator of CVD development. In this study, we ai…

article 2022
Evaluation of atherosclerosis‐related biomarkers during perimenopause: A prospective cohort study in women with endometriosis
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15447

AIM: Endometriosis is linked to asymptomatic atherosclerosis and increases the risk of cardiovascular disease (CVD). Vascular function tests are used to assess atherosclerosis, an important indicator of CVD development. In this study, we ai…

article 2022
Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study
Endocrine journal ·doi:10.1507/endocrj.ej22-0158

Dienogest (DNG) is widely used to treat dysmenorrhea associated with estrogen-dependent diseases such as endometriosis and adenomyosis. DNG becomes unnecessary after menopause when estrogen secretion declines drastically. However, there are…

article 2022
Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study
BMC women's health ·doi:10.1186/s12905-022-01711-3

Abstract Background In women with endometriosis, the association between ovarian function, hormones, and bone mineral density (BMD) is unclear. Therefore, this study aimed to elucidate the association between changes in bone mineral density…

preprint 2021
Relationship Between Bone Mineral Density and Ovarian Function in Perimenopausal Women With Endometriosis: A Prospective Study
·doi:10.21203/rs.3.rs-778798/v1

Abstract Background In women with endometriosis, the association between ovarian function, hormones, and bone mineral density (BMD) is unclear. Therefore, this study aimed to elucidate the correlation between changes in bone mineral density…

article 2018
The risk of dyslipidemia after a cystectomy or oophorectomy in endometriosis